chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Situation: Patient at the Covid vaccine clinic receiving her first Moderna vaccination. Background: Hx of allergies, has epi pen. Assessment: At the end of the 30 min monitoring period the patient complains of a slight scratch in her throat to MD. Patient is in no acute distress. MD offered Benadryl but the patient states she has a long drive ahead of her, she denies the Benadryl. Patient positioned supine with head elevated 40 degrees on gurney for further assessment and observation with MD. Vital signs: 1517: 128/83, P 57, regular, O2 sat 98% on RA. 1527: 134/87, P 63, O2 sat 98% on Ra. The patient states she is feeling better.  Recommendation: MD is releasing the patient. The patient will go to the pharmacy to pick up some Claritin, per MD recommendation.
PATIENT SAID THAT THE DAY AFTER VACCINE RECEIVED, HIS ARM SWELLED SEVERELY AND GOT VERY RED AND HOT.  HE WENT TO HOSPITAL AND THEY CHECKED HIS BLOOD FOR VIRUSES AND BACTERIA. THEY KEPT HIM AND GAVE HIM IV ANTIBIOTICS AND RELEASED HIM WITH ORAL ANTIBIOTICS WHICH APPEARED TO BE CAUTIONARY SINCE PT CLAIMED NO BACTERIA FOUND AND HE SAID THEY BELIEVED IT TO BE A VIRUS.
Developed left arm pain, flu like sx, the following day tired, aching all over, increased left arm pain, swelling and stiffness, chills and low grade fever 05/18/06, took Tylenol, 5/20/2006 developed dizziness, erythema raised area below injection site, BP decreased 9/55 with home machine 10mm below normal. Larger area redness and erythema on 5/21/06. presents today 5/22/06 for evaluation no fever, chills, left deltoid sore, erythema 5cm x 15cm.
is now showing some red rashes. Got in both arms, greased in elbow; This is a spontaneous report from a Pfizer-sponsored program. A non-contactable female consumer (patient). A female patient of unspecified age had received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: unknown), via an unspecified route of administration on 06Feb2021 as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Patient had stated that after 2nd dose of vaccine yesterday, approximately on unknown date in Feb2021, (reported as now) showing some red rashes. Got in both arms, greased in elbow. Patient wants to let us know about this if this is okay.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
58 years old gentleman seen today.  He has anticoagulant therapy is a 58-year-old gentleman otherwise quite healthy COVID-19 vaccination , received in May 2021.  Approximately  6 weeks later  He developed acute shortness of breath, tightness in the chest evaluated emergency room(6/16/2021).. 80 NGO was done and he was diagnosed of bilateral pulmonary embolism with  subsegmental blood clots in both lungs.  Placed on heparin and subsequently switch him to Xarelto charged home seen by cardiology with subsequent referral to us additional evaluation including the duration of anticoagulant therapy.
It started with sore throat on 03/31/2023. I tested positive for COVID-19 04/02/2023 and had runny nose, headache, low grade fever, unable to eat, fatigue. I did a telehealth visit on 04/03/2023 and provider prescribed PAXLOVID for 5 day treatment. I tested negative for COVID-19 on 04/09/2023.
Ringing in ears; Runny Nose; This case was reported by a pharmacist via call center representative and described the occurrence of ringing in ears in a 65-year-old female patient who received Herpes zoster (Shingrix) (batch number 5H29X, expiry date 6th July 2023) for prophylaxis.   On 9th June 2022, the patient received the 1st dose of Shingrix (intramuscular). In June 2022, less than a week after receiving Shingrix, the patient experienced ringing in ears and runny nose. On an unknown date, the outcome of the ringing in ears and runny nose were not recovered/not resolved.   It was unknown if the reporter considered the ringing in ears and runny nose to be related to Shingrix.     Additional Information: GSK Receipt Date: 10-JUN-2022 Reporter's comment: The reporter was the pharmacist.  The patient received Shngrix vaccine in right arm the day before reporting. She stated the patient called this morning to report ringing in her ears and a runny nose.
Menstrual cycle started 8 days early and began a few hours after receiving my first dose of the vaccine.
Lightheadedness, almost passed out so they kept me longer & it happened again.  Had to pull over side of road on way home as I almost blacked out.  Happened throughout the day and then my blood pressure went to 160/90.  That has lowered but still has not returned to normal.
January 06, 2021 ?11:50am shot received Right arm ?21:00 right neck pain  ?22:00 right ear pain ?22:24 right headache and neck pain  January 07, 2021 ?07:00 sore throat ?07:00 fatigue, extreme January 8, 2021 ?07:00 fatigue still extreme
Encephalitis. Fever, elthargy, alt. conscious, personality, stiff neck, somnolence, seizures, sore throat.  A 60-day follow up report received 6/10/2003 adds no new info. Annual follow up on 03/17/04: "It is unknown if pt recovered from adverse events."
Dizziness started within 30 minutes after injection on 01/08/21 and felt "off". On 01/09/21 approx. 0800 Patient began feeling body aches, fevers, injection site pain, increased dizziness, and nausea. At approximately 1pm patient began vomiting and having diarrhea. Symptoms worsened over the next couple hours to where patient was unable to walk without stumbling. Wife witnessed patient becoming very pale and almost pass out at approx. 5:30pm. Patient states he feels like he's in slow motion. Patient is unable to maintain balance when walking and reports increasing fatigue and weakness.
p/ pt recv vax approx 3yr later pt devel 24 varicella-like lesions. rash was semi-pruritic
Patient received one extra dose; Diarrhea; This case was reported by a other health professional via call center representative and described the occurrence of diarrhea in a 1-year-old female patient who received Flu Seasonal QIV Quebec (FluLaval Tetra 2020-2021 season) (batch number 494S5, expiry date 30th June 2021) for prophylaxis.   Co-suspect products included flu seasonal qiv quebec pre-filled syringe device (Flulaval Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis.   Concomitant products included Flu Seasonal QIV Quebec (FluLaval Tetra 2020-2021 season) and Flu Seasonal QIV Quebec (FluLaval Tetra 2020-2021 season).   On 1st December 2020, the patient received the 3rd dose of FluLaval Tetra 2020-2021 season and Flulaval Tetra Pre-Filled Syringe Device. On 1st December 2020, unknown after receiving FluLaval Tetra 2020-2021 season and Flulaval Tetra Pre-Filled Syringe Device and an unknown time after receiving FluLaval Tetra 2020-2021 season and FluLaval Tetra 2020-2021 season, the patient experienced extra dose administered. In December 2020, the patient experienced diarrhea. On an unknown date, the outcome of the diarrhea and extra dose administered were unknown.   It was unknown if the reporter considered the diarrhea to be related to FluLaval Tetra 2020-2021 season and Flulaval Tetra Pre-Filled Syringe Device.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were reported as follows: The reporter was medical assistant. All the vaccines had the same lot number and expiration date. It was reported that the patient received one extra dose of Flulaval, which led to extra dose administered and after that the patient experienced diarrhea. The reporter consented to follow up.
itchy; red; tender; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itchy), VACCINATION SITE ERYTHEMA (red) and VACCINATION SITE PAIN (tender) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history reported).    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (itchy), VACCINATION SITE ERYTHEMA (red) and VACCINATION SITE PAIN (tender). At the time of the report, VACCINATION SITE PRURITUS (itchy), VACCINATION SITE ERYTHEMA (red) and VACCINATION SITE PAIN (tender) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
36 hours after vaccination I woke up at 3:15am with severe abdominal cramping, dizziness, excessive thirst, and nausea. The area around the injection site was swollen, red, and painful to touch. I fell over on my way to the toilet due to extreme dizziness. I had three hours of diarrhea, and then took pepto bismal and bennydryl. Those remedies worked and my symptoms subsided and I was able to fall back asleep by 4am. In the morning I felt normal, besides some remaining pain and redness surrounding the injection site.
ABOUT FEBRUARY 6 A RATHER LARGE, OBLONG PINK AREA APPEARED ON MY LEFT ARM AROUND THE VACCINATION SITE.  THE AREA APPEARS TO SLOWLY GROW, SINCE I NOTICED IT ON FEBRUARY 6.   THERE HAS BEEN SOME ITCHING AND SLIGHT DISCOMFORT.
When scheduled home bound visit staff was told by the patient that it was a booster dose that was needed.  After booster dose given, when entered into database was realized that it was second dose in primary series.
More than 36 days have passed since first dose given; tested positive for Covid Infection; This spontaneous case was reported by an other health care professional and describes the occurrence of SARS-COV-2 TEST POSITIVE (tested positive for Covid Infection) and INCORRECT DOSE ADMINISTERED (More than 36 days have passed since first dose given) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Jan-2021, the patient experienced SARS-COV-2 TEST POSITIVE (tested positive for Covid Infection). On an unknown date, the patient experienced INCORRECT DOSE ADMINISTERED (More than 36 days have passed since first dose given). At the time of the report, SARS-COV-2 TEST POSITIVE (tested positive for Covid Infection) outcome was unknown and INCORRECT DOSE ADMINISTERED (More than 36 days have passed since first dose given) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Relevant concomitant medications were not reported.  Treatment medication was not provided.
She got her vaccine, and had the typical ache in the arm.  It wasn't until the 17th that she noticed that she had tingling in which it may have triggered peripheral artery disease which she may have.  Then she thought to herself is it possible that her hair doing what it is doing, (hair shedding), started receding and not growing back.  When she got the tingling in her arms and things, she thought and was wondering after hearing complaining about the vaccines was from that.  She then thought that maybe her reactions were from the vaccines.    She is having hair loss on the skin of the forehead where the hair beings, receding about 1/2", at the temples, and on top of her head, crown area portion has thinned out quite a bit.  It seems to be concentrated there.  There is shedding elsewhere, but these are the areas that are mostly offended by whatever this vaccine may be doing.
This spontaneous report as received from a healthcare worker refers to unspecified patients of unknown age. The patient's pertinent medical history and concurrent conditions were not reported. No previous drug reactions or allergies were reported. The reporter stated that doses of GARDASIL 9 (dosing details were not reported) lot # L019297 with an expiry date 18-AUG-2017 which were exposed to temperature 31.1F for a time frame of 2 hours on 29-JAN-2015, were administered to unspecified patients on 19-FEB-2016. No concomitant medications were reported. No adverse effects were reported. This is one of the two reports received from the same reporter. (case # 1602USA012422). Additional information has been requested.
headache; fever/as high as 102.9 degrees Fahrenheit, now (22Dec2020) it's just over 100.0 degrees Fahrenheit; This is a spontaneous report from a contactable nurse.  A 31-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), lot number: EK5730, via an unspecified route of administration, at the right arm, from 17Dec2020 18:30 at a single dose for covid-19 immunization. Medical history included attention deficit hyperactivity disorder (ADHD), osteoarthritis (OA); patient already suffer joint pain and her current joint pain is no worse than usual, Raynaud's, palpitations and joint pain. Concomitant medications included amfetamine aspartate monohydrate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (MYDAYIS); amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL); and ibuprofen (IBUPRO).  It was reported that the patient has had fever daily. Initially on 18Dec2020 at 9:00, it was as high as 102.9 degrees Fahrenheit, now (22Dec2020) it's just over 100.0 degrees Fahrenheit. She also has had a headache daily(reported as started on 18Dec2020 at 9:00), but today's headache is much worse than previous days. The patient underwent lab tests and procedures on 18Dec2020 which included sars-cov-2 test/COVID-19 test/nasal swab with negative result. Outcome of events was reported as not recovered.  Therapeutic measures were taken as a result of events headache and fever included OTC medications (unspecified).  Follow-up attempts are completed. The information on the batch/lot number was obtained.
Excessive heart racing/restless/major fatigue starting approx 2 hours and lasting about 2 days. Did go to ER. Also very weak.
Feels dizzy and worsened; Having extreme pain in her head, which is pounding really bad and worsened; Feels really, really tired and worsened; Can't stand up; This is a spontaneous report from a contactable consumer or other non hcp (parent). A 13-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 2 via an unspecified route of administration on 09Jun2021 (age at vaccination 13 years), (Batch/Lot number: Unknown, Expiry Date: Unknown, as reported) as DOSE 2, SINGLE for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient had no prior vaccinations within four weeks. The patient previously took bnt162b2 dose 1 for covid-19 immunization. Father stated that his 13-year-old daughter received her 2nd dose of the Pfizer COVID 19 Vaccine yesterday (09Jun2021). Since this morning (10Jun2021), patient had extreme pain in her head, which was pounding really bad and worsened, very tired, as well as dizziness, she could not stand up. He did not know what to do. Everything started at the same time this morning (10Jun2021) and had all been progressing and had gotten worse. Him and his wife were both at work. Was asking if they should call the hospital. Was advised to contact their primary care provider for medical advice. She had virtual school and was able to do that. No treatment received for the adverse events. The clinical outcome of the events was not recovered at the time of report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
The patient had a shingles outbreak approximately 1 month (July 30, 2017) after receiving the vaccine. She woke up the morning of July 30, 2017 with what she thought were spider bites over one side of her back. She went to her doctor a couple of weeks later for an unrelated issue and was diagnosed with shingles at that time.
Covid + patient came in to receive Regeneron started at 13:03.  13:40 notified NP that he was having itchy tongue and itchy throat.  Gradual onset. Order received to administer 25mg  Benadryl IV.  Reaction resolved after drug discontinued.   Patient was held in facility for an extra hour with no other complaints.
11 day post vax t105, stiff neck, APAP given for fever; t105 x 3 days; 4th day swelling left side of neck & face; 5th day t98;
Within 5-6 hrs difficulty lifting. It's been ongoing pain. Getting less, but still bothering patient. Left arm shoulder. Still difficulty to sleep on that side.
09/05/2017 12:00PM Left upper arm irritation. Left arm irritation x 1 week. Patient had a flu shot and reports itching and mild irritation at the time. Symptoms have progressed to pain and warmth. More redness is appearing. She tried ice. Pain is 6/10 and worse if someone touches it. She denies previous vaccine reactions. 09/06/2017 3:00PM Acute Visit Urgent Care follow up---flu injection site is inflamed and painful. Patient is here to follow-up for urgent care visit She had her flu vaccine week ago, she started with swelling, redness, small bruise around injection site within the next 24-48 hours. She continue to have his redness and itching and pain, she was advised to follow up she was diagnosed with the cellulitis, she was given antibiotic her redness is slowly getting better, pain is slowly getting better.
A few hours after she was vaccinated these problems began; she was very fussy and didn't want to eat and she always had a great appetite before this. She was holding her head and screaming in pain. She had a loose smelly bowel movement, yellow in color. She didn't sleep well that night due to crying in pain. The next morning I noticed her forehead looked swollen and there was no reason for that because she didn't hit her head or fall on anything. Her cheeks are puffy and eyes look sunken in. She doesn't seem to be interacting with people as much, no interest in playing with her friend, would rather take a toy and sit by herself. Doesn't say words she said very clear, acts as if she doesn't know them anymore. When I tried getting her to say them she looks confused and gets frustrated because she can't say them. She has almost no appetite and won't eat her favorite snacks because of the texture. She rests her head on the floor and other times banging her head on the back of her chair or hits herself. Other times she holds her head and moans in pain. Also pulls her hair and ears. Runny nose, congested sounding in her chest, raspy breathing and at other times holding her breath when she's sleeping. She's continued to have 3-5 yellow loose strong smelling stool a day. Seems to be more sleepy, tired and fussy. Sleeping more hours during the day than before. When she wakes up her eyes are crusty. No interest in reading her books or pointing at things and saying "what's that" and she was always curious what things are, seems zombified. The day after her shots she held her breath in her sleep twice. Sometimes when sleeping she moans in pain but doesn't wake up, stirs in her sleep like she's uncomfortable. I brought her back to the doctors on 01/11/2019 because I am very concerned  about her.
About 10 minutes after recieving the flu vaccination patient started to feel hot, nauseous, dizzy and a little shakey. She rested for a few minutes and started to feel a little bit better so she went back to work. She then started to feel even worse and about 10 minutes later she vomited for the first time. She then rested for 10 minutes then vomited a second time. We had her lay down and started fanning her because she was still feeling the same symptoms. About 30 minutes after that she vomited a third time. We were finally able to get a hold of our company nurse and she suggested that we take her to the urgent care for a check up.
The problem started with a lot of pain in the left thigh that hurt at the injection spot section that hurt with each step I took as I walked and with movements like when I was lowering to sit on the floor or raising up from sitting on the floor. That continued for approximately 48 hours. After, that, there was not that kind of pronounced pain at the injection section. There is still sometimes pain at the injection section when I walk, lay or sit. This pain is less sharp than in the pain that lasted for approximately 48 hours. There is also pain in the lower left part of my back. There is pain in the left part of my butt, the back of my left thigh, the front and back of my lower left leg, the left foot and the left knee. The treatment was physical therapy, ibuprofen and stretches. The outcome is temporary improvement from treatment but ongoing problems.
Abstract: Typhoid vaccination is recommended before travel to countries where typhoid fever is endemic, though little information is available on its effectiveness in travelers. We estimated typhoid vaccination effectiveness (VE) by comparing vaccination status in cases of typhoid fever and paratyphoid fever (Salmonella Paratyphi A infection, against which typhoid vaccine offers no protection) reported. We included travelers to a specific area and excluded persons <2 years old and cases in which vaccination status was not reported. From 2008 through 2011, 744 eligible cases (602 typhoid, 142 paratyphoid A) were reported to CDC. Typhoid vaccination was reported for 5% (29/602) of typhoid patients and for 20% (29/142) of paratyphoid A patients. Estimated VE was 80% (95% confidence interval, 66-89%). Because of missing data, we could not estimate VE for specific vaccines. We demonstrated moderate effectiveness of typhoid vaccination in travelers, supporting vaccination recommendations. Initial report retrieved from the scientific literature on 02 July 2014. Six patients, among vaccinated typhoid patients for whom the type of vaccine was reported, experienced typhoid after being vaccinated with a parenteral TYPHOID VACCINE (manufacturer unknown, lots and dates of administration not reported). Ages and genders were not reported. All patients had been vaccinated within five years of diagnosis, which occurred between 2008 and 2011. Additional information, including treatment, outcome, and disease course, were not reported. Documents held by sender: None.
it was rpt fr MD concerning pt who was vax & 2wks following pt exp inject site rash, described as red circle w/a hard center. no further info avail
Pt recvd 2 doses of Hep B vax & following 2nd dose of Hep B vax devel rash over entire body; No further details were provided;
Began with mild headache and nausea. Progressed to migraine within an hour and nausea increased. Became tired with all over muscle achiness.  3 hours later chills began, despite the house being 71 degrees. An hour later temperature (via oral) registered 100.5. Side effects were dissipating by 8pm, and by 10:30AM the following day ( 6/17/19) no symptoms at all were present.
Patient received a second dose of Moderna Bivalent vaccine. She received her first dose on 05/09/2023 and the second dose on 06/09/2023. I spoke with patient on 7/27/2023 regarding the second dose given in error. She did not experience any adverse reactions to either dose. Patient gave me her provider's clinic information so that I could contact them as well regrading the error. I called to reach her provider. I was told the provider she used to see in no longer at that practice and she has not established care with another provider at that office.